
No genetic association between A118G polymorphism of μ-opioid receptor gene and schizophrenia and bipolar disorders
Author(s) -
Shaghayegh Yazdani,
Vahid Salimi,
Mohammad Reza Eshraghian,
Mohammad Shayestehpour,
Alireza Pourtalebi-Firoozabadi,
Bizhan Romani,
Azadeh Shadab,
Mohammad Reza Aghasadeghi,
Jila Yavarian
Publication year - 2017
Publication title -
indian journal of psychiatry/indian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.485
H-Index - 34
eISSN - 1998-3794
pISSN - 0019-5545
DOI - 10.4103/psychiatry.indianjpsychiatry_53_17
Subject(s) - single nucleotide polymorphism , bipolar disorder , snp , medicine , genotype , polymorphism (computer science) , schizophrenia (object oriented programming) , genetic association , allele , candidate gene , genetics , bioinformatics , gene , psychiatry , biology , lithium (medication)
Schizophrenia (SZ) and bipolar disorder (BD) are chronic and multifactorial psychiatric disorders that might be affected by different genes in combination with environmental factors. There is evidence of association between polymorphisms of μ-opioid receptor gene (OPRM1) with these disorders.